Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Lubiprostone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104557845A reveals a mild transfer hydrogenation route for Lubiprostone. Achieve high purity and cost reduction in API intermediate manufacturing with scalable methods.
Patent CN104140410A details a high-purity Lubiprostone preparation method offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Novel atmospheric pressure method for lubiprostone using triethylsilane. Reduces equipment costs and improves purity for pharmaceutical manufacturing.
Patent CN103787942B reveals a scalable HWE reaction route for lubiprostone intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.